Drug details

Cabometyx (cabozantinib tablets)

type of Antineoplastic Tyrosine Kinase Inhibitors

Cabometyx (cabozantinib) Tablets is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma (RCC) who have received prior anti-angiogenic therapy.

The following drugs are related to Cabometyx, either as a replacement or used together:

• Afinitor (everolimus tablets)
• Proleukin (aldesleukin for injection)
• Alymsys (bevacizumab-maly injection)
• Avastin (bevacizumab)
• Inlyta (axitinib)
• Welireg (belzutifan tablets)
• Betaseron (interferon beta-1b)
• CellCept (mycophenolate mofetil)
• Libtayo (cemiplimab-rwlc injection)
• Fotivda (tivozanib capsules)
• Lytgobi (futibatinib tablets)
• Sancuso (granisetron transdermal system)
• Hepzato (melphalan for injection)
• Imjudo (tremelimumab-actl injection)
• Opdivo (nivolumab injection)
• Votrient (pazopanib tablets)
• Peg-Intron (peginterferon alfa-2b)
• Sutent (sunitinib malate)
• Torisel (temsirolimus injection)